Literature DB >> 12150921

The HIV-1 vaccine race.

David D Ho1, Yaoxing Huang.   

Abstract

There is an urgent need to come up with a vaccine that will curtail the spread of HIV-1. To be successful, the scientific community must work in concert to develop sound strategies based on a deeper understanding of the virus. Significant technological advances are also required to overcome the unique obstacles posed by HIV-1. Some of the challenges we face in this endeavor are discussed here.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150921     DOI: 10.1016/s0092-8674(02)00832-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  17 in total

1.  Evolutionary dynamics of escape from biomedical intervention.

Authors:  Yoh Iwasa; Franziska Michor; Martin A Nowak
Journal:  Proc Biol Sci       Date:  2003-12-22       Impact factor: 5.349

2.  Model-based inference of recombination hotspots in a highly variable oncogene [corrected].

Authors:  G Greenspan; D Geiger; F Gotch; M Bower; S Patterson; M Nelson; B Gazzard; J Stebbing
Journal:  J Mol Evol       Date:  2004-03       Impact factor: 2.395

Review 3.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

4.  Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV.

Authors:  Anne S De Groot; Daniel S Rivera; Julie A McMurry; Soren Buus; William Martin
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

5.  Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.

Authors:  Ruy M Ribeiro; Li Qin; Leslie L Chavez; Dongfeng Li; Steven G Self; Alan S Perelson
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

6.  Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine.

Authors:  Lauren Levitz; Ousmane A Koita; Kotou Sangare; Matthew T Ardito; Christine M Boyle; John Rozehnal; Karamoko Tounkara; Sounkalo M Dao; Youssouf Koné; Zoumana Koty; Soren Buus; Leonard Moise; William D Martin; Anne S De Groot
Journal:  Vaccine       Date:  2012-10-24       Impact factor: 3.641

7.  Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG.

Authors:  Pablo López; Omayra De Jesús; Yasuhiro Yamamura; Nayra Rodríguez; Andrea Arias; Raphael Sánchez; Yadira Rodríguez; Vivian Tamayo-Agrait; Wilfredo Cuevas; Vanessa Rivera-Amill
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-23       Impact factor: 2.205

8.  Intracellular dynamics of HIV infection.

Authors:  Janka Petravic; Paula Ellenberg; Ming-Liang Chan; Geza Paukovics; Redmond P Smyth; Johnson Mak; Miles P Davenport
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Reassessing the human immunodeficiency virus type 1 life cycle through age-structured modeling: life span of infected cells, viral generation time, and basic reproductive number, R0.

Authors:  Christian L Althaus; Anneke S De Vos; Rob J De Boer
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.

Authors:  Leor S Weinberger; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.